Inflammation Mediates Body Weight and Ageing Effects on Psychomotor Slowing.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 10 2019
Historique:
received: 23 01 2019
accepted: 07 10 2019
entrez: 2 11 2019
pubmed: 2 11 2019
medline: 20 11 2020
Statut: epublish

Résumé

Inflammation (immune system activation) affects neuronal function and may have consequences for the efficiency and speed of functional brain processes. Indeed, unusually slow psychomotor speed, a measure predictive of behavioural performance and health outcomes, is found with obesity and ageing, two conditions also associated with chronic inflammation. Yet whether inflammation is the mediating factor remains unclear. Here, we assessed inflammation by indexing interleukin-6 level in blood and measured psychomotor speed as well as indices of selective visual attention in young (mean = 26 years) or old (mean = 71 years) adults (N = 83) who were either lean or currently significantly overweight (mean body mass index = 22.4 and 33.8, respectively). Inflammation was positively and significantly correlated with psychomotor speed, age, and body mass index but not with attention measures. Using mediation analyses we show for the first time that inflammation fully accounts for the significant psychomotor slowing found in those with high BMI. Moreover, we further show that age-related psychomotor slowing is partially mediated by inflammation. These findings support the proposal that reducing inflammation may mitigate weight- and age-related cognitive decline and thereby improve performance on daily tasks and health outcomes more generally.

Identifiants

pubmed: 31673089
doi: 10.1038/s41598-019-52062-3
pii: 10.1038/s41598-019-52062-3
pmc: PMC6823347
doi:

Substances chimiques

IL6 protein, human 0
Interleukin-6 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15727

Références

Obes Surg. 2018 Feb;28(2):532-540
pubmed: 28849437
Nutr Res Rev. 2008 Dec;21(2):117-33
pubmed: 19087366
Nat Rev Neurosci. 2004 Feb;5(2):87-96
pubmed: 14735112
Front Neurosci. 2014 Nov 19;8:375
pubmed: 25477778
J Neurosci Nurs. 2012 Aug;44(4):206-17
pubmed: 22743812
Exp Aging Res. 2010 Jul;36(3):287-305
pubmed: 20544449
Front Immunol. 2017 Dec 07;8:1745
pubmed: 29270179
Neuron. 2017 Jul 19;95(2):233-235
pubmed: 28728016
Neurobiol Aging. 2008 Aug;29(8):1237-46
pubmed: 17363113
Brain Cogn. 2011 Mar;75(2):205-10
pubmed: 21251744
Neuron Glia Biol. 2007 Aug;3(3):245-53
pubmed: 18634615
Mol Nutr Food Res. 2014 Jan;58(1):136-46
pubmed: 23847095
J Obes. 2016;2016:9040248
pubmed: 26904277
Clin Sci (Lond). 2015 Oct 1;129(8):757-67
pubmed: 26223840
Nat Neurosci. 2007 Nov;10(11):1387-94
pubmed: 17965659
J Am Geriatr Soc. 2012 Nov;60(11):2070-4
pubmed: 23110784
Brain Cogn. 2017 Oct;117:26-32
pubmed: 28700954
Nat Rev Neurosci. 2017 Nov 16;18(12):741-752
pubmed: 29142296
Psychosom Med. 2006 Nov-Dec;68(6):895-903
pubmed: 17132839
Neurobiol Aging. 2009 Apr;30(4):507-14
pubmed: 19231028
Ageing Res Rev. 2011 Jul;10(3):319-29
pubmed: 21145432
Front Aging Neurosci. 2018 Aug 06;10:236
pubmed: 30127734
Neuropsychopharmacology. 2017 Jan;42(1):216-241
pubmed: 27480574
J Am Geriatr Soc. 2008 Sep;56(9):1618-25
pubmed: 18691275
J Behav Med. 2012 Apr;35(2):190-9
pubmed: 21503710
Neuroimage. 2005 Jun;26(2):471-9
pubmed: 15907304
Exp Physiol. 2017 Dec 1;102(12):1683-1699
pubmed: 28983981
Hum Brain Mapp. 2010 Jul;31(7):1052-64
pubmed: 19998366
Eur J Neurol. 2013 Jun;20(6):899-906, e76-7
pubmed: 23323838
Obesity (Silver Spring). 2010 Nov;18(11):2131-7
pubmed: 20814415
Dev Sci. 2013 Mar;16(2):269-286
pubmed: 23432836
Ann Behav Med. 2010 Oct;40(2):218-27
pubmed: 20652462
Curr Pharm Des. 2014;20(38):6048-57
pubmed: 24641220
Front Aging Neurosci. 2011 Nov 15;3:17
pubmed: 22110440
J Clin Neurosci. 2006 Jun;13(5):540-6
pubmed: 16723232
J Immunol Res. 2018 May 8;2018:1838921
pubmed: 29854828
Neurobiol Learn Mem. 2010 Nov;94(4):561-7
pubmed: 20875866
Front Aging Neurosci. 2015 Aug 18;7:155
pubmed: 26347646
Obes Res Clin Pract. 2015 Mar-Apr;9(2):93-113
pubmed: 25890426
Front Psychol. 2014 Jul 29;5:781
pubmed: 25120503
J Am Coll Cardiol. 2002 Feb 20;39(4):578-84
pubmed: 11849854
Front Psychiatry. 2015 Jan 26;5:196
pubmed: 25674065
Brain Behav Immun. 2012 Oct;26(7):1072-6
pubmed: 22749892
Int J Obes (Lond). 2013 Feb;37(2):296-302
pubmed: 22450854
Front Psychol. 2012 Aug 31;3:311
pubmed: 22969741
J Gerontol A Biol Sci Med Sci. 2010 Jan;65(1):57-62
pubmed: 19349594
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2007 Jul;14(4):353-69
pubmed: 17612813
Psychoneuroendocrinology. 2013 Jun;38(6):744-51
pubmed: 23021498
J Am Geriatr Soc. 2007 May;55(5):708-16
pubmed: 17493190
Brain Behav Immun. 2017 Feb;60:63-70
pubmed: 27658542
BMJ Open. 2012 Jul 02;2(4):
pubmed: 22761287
Brain Behav Immun. 2007 Feb;21(2):153-60
pubmed: 17088043
J Neurosci Methods. 2007 May 15;162(1-2):8-13
pubmed: 17254636
Psychol Med. 2011 Jan;41(1):151-62
pubmed: 20380782
Nat Rev Immunol. 2007 Feb;7(2):161-7
pubmed: 17220915
PLoS One. 2017 May 5;12(5):e0176898
pubmed: 28475603
Brain Cogn. 2016 Feb;102:65-79
pubmed: 26760449
Eat Weight Disord. 2006 Mar;11(1):e15-9
pubmed: 16801734
Neuropsychology. 2006 Mar;20(2):133-43
pubmed: 16594774
Nat Rev Neurosci. 2012 Mar 07;13(4):240-50
pubmed: 22395804
J Pers Assess. 1996 Feb;66(1):20-40
pubmed: 8576833
Neuropsychopharmacology. 2017 Jan;42(1):28-35
pubmed: 27402496
Biol Psychiatry. 2008 Jun 1;63(11):1022-9
pubmed: 18242584
Scand J Psychol. 2009 Dec;50(6):660-7
pubmed: 19930267
Psychol Rev. 1996 Jul;103(3):403-28
pubmed: 8759042
J Cogn Neurosci. 2002 Apr 1;14(3):340-7
pubmed: 11970796
Arch Gen Psychiatry. 2001 May;58(5):445-52
pubmed: 11343523
Annu Rev Neurosci. 1990;13:25-42
pubmed: 2183676
J Neurosci. 2018 Oct 10;38(41):8889-8904
pubmed: 30201764
Biol Psychiatry. 2009 Sep 1;66(5):407-14
pubmed: 19423079
J Nutr Health Aging. 2015 Apr;19(4):468-73
pubmed: 25809812
Front Aging Neurosci. 2011 Sep 13;3:12
pubmed: 21949507
PLoS One. 2016 Nov 10;11(11):e0165799
pubmed: 27832117
Acta Neuropathol. 2001 Mar;101(3):249-55
pubmed: 11307625
Neuroimage. 2019 Nov 15;202:116098
pubmed: 31415883
Obes Rev. 2011 Sep;12(9):740-55
pubmed: 21991597
Psychon Bull Rev. 2018 Feb;25(1):58-76
pubmed: 28685272
Compr Psychiatry. 2007 Jan-Feb;48(1):57-61
pubmed: 17145283
J Int Neuropsychol Soc. 2010 Sep;16(5):877-89
pubmed: 20663241
Brain Behav Immun. 2015 Aug;48:195-204
pubmed: 25882911
Neuroepidemiology. 2010;34(4):222-9
pubmed: 20299802
Am J Clin Nutr. 2004 Apr;79(4):544-51
pubmed: 15051595
Gerontology. 2004 Sep-Oct;50(5):303-8
pubmed: 15331859
Curr Obes Rep. 2018 Mar;7(1):50-59
pubmed: 29430616
Brain Behav Immun. 2018 Oct;73:216-221
pubmed: 29742460
J Psychosom Res. 2017 Mar;94:47-55
pubmed: 28183402
Obes Rev. 2011 May;12(5):e426-37
pubmed: 21348917
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
Neurology. 2007 Sep 4;69(10):979-85
pubmed: 17785666
Br J Clin Psychol. 2005 Jun;44(Pt 2):227-39
pubmed: 16004657
Int J Obes (Lond). 2006 Jan;30(1):201-7
pubmed: 16231030

Auteurs

Leonie J T Balter (LJT)

School of Psychology, University of Birmingham, Birmingham, B15 2TT, UK. leonie.balter@su.se.
Psychology Department, Clinical Psychology, University of Amsterdam, Amsterdam, 1018 WT, The Netherlands. leonie.balter@su.se.

Suzanne Higgs (S)

School of Psychology, University of Birmingham, Birmingham, B15 2TT, UK.

Sarah Aldred (S)

School of Sport, Exercise, and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

Jos A Bosch (JA)

Psychology Department, Clinical Psychology, University of Amsterdam, Amsterdam, 1018 WT, The Netherlands.

Jane E Raymond (JE)

School of Psychology, University of Birmingham, Birmingham, B15 2TT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH